DEAR DR. ROACH: Could you please advise what the current recommendation is as far as follow-up colonoscopies are concerned? It has always been my understanding from what I have read that virtually all ...

Colon cancer is the second leading cause of cancer-related deaths behind lung cancer. The current guidelines recommend that those at average risk for colon cancer have their first colonoscopy at the ...

A new study published in the journal Gastroenterology supports the guidelines suggesting patients ages 50 and older at low risk of colon cancer should receive a screening colonoscopy every 10 years ...

The jury is still out on several guidelines regarding screening colonoscopies, despite rising colorectal cancer rates. Colorectal cancer in the U.S. is on the rise in 2024, officially becoming the ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window After the ...

Surveillance may be overperformed following detection of small adenomas (<1 cm in diameter) or polyps by colonoscopy. Guidelines recommend colonoscopy at 3 years for large adenoma and 3–5 years for ...

It’s the fourth most common cancer in the U.S., and a recent study showed colon cancer is on the rise in younger adults. The American Cancer Society recommends adults at average risk start regular ...

NEW YORK (Reuters Health) - UK guidelines for colon cancer surveillance might be better at catching pre-cancerous polyps early on than U.S. ones, a new study suggests. Because the UK guidelines ...

CLEVELAND, Ohio — Dan Adler, 50, was in the middle of getting his sons sent off to college, but an alarming medical condition, rectal bleeding, told him not to put off getting a colonoscopy. His ...

Learning more about colon cancer is important if you are 45 or older, or have a history of colon cancer in your family. March is Colon Cancer Awareness Month. More than 140,000 new cases of colorectal ...

Family physicians' colonoscopy rates decreased from 11.32% in 2016 to 6.73% in 2021, influenced by patient demographics and financial factors. TAS-102 plus bevacizumab is cost-effective in China but ...